Virtual reality surgical training wins industry attention with scalable model

Tern plc

A virtual reality training platform developed by Fundamental XR and Orbis International has been awarded Gold in a major technology competition, highlighting how immersive tools are starting to gain traction in global medical education.

This programme, focused on ophthalmic surgery, allows medical trainees to practise procedures in a fully immersive virtual environment, without the limitations of physical equipment, live supervision or real-world patient risk. The result is a more accessible, standardised form of surgical education, especially valuable in countries where hospital training resources are limited or overstretched.

What sets this initiative apart is its focus on real-world application. The technology has been designed to fit the workflow and constraints of medical education systems in lower-resource settings. This combination of technical quality and real-world relevance is what earned the recognition, and it signals a step forward for VR in professional training markets.

Orbis brings decades of experience in eye care and surgical training around the world, while Fundamental XR provides the technical capability to deliver high-fidelity, scalable simulations. Together, they have built a tool that solves a pressing educational problem with modern technology, a clear use case with long-term potential.

Tern plc (LON:TERN) backs exciting, high growth IoT innovators in Europe. They provide support and create a genuinely collaborative environment for talented, well-motivated teams.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Fundamental XR expands access to immersive training with web-enabled platform

Its new Immersive Web platform brings immersive training into the browser, lowering adoption barriers and broadening enterprise reach.

GLP-1 receptor agonists: Strategic market shift

Rapid uptake, evolving regulation and digital integration are reshaping the investment case for metabolic health therapies.

The Cyber Resilience Act forces a security reset for connected device makers

Device Authority helps manufacturers operationalise Cyber Resilience Act compliance through automated device identity and secure update management.

Pharmaceutical groups move closer to the consumer in strategic marketing reset

Pharmaceutical marketing is shifting towards direct consumer engagement, reshaping how companies compete and manage risk in a digital environment.

Changing clinician behaviour reshapes commercial strategy for 2026

As clinician engagement becomes more digital and measurable, companies that act on behavioural data can improve targeting, reduce risk and strengthen competitive positioning in 2026.

Tern Plc launches £384,408 Open Offer at 0.40p per share

Tern Plc has announced an Open Offer to raise up to £384,408 through the issue of up to 96,101,957 shares at 0.40p each, a 20% discount to the 12 February 2026 closing price.

Search

Search